Mastercard slips in thin year-end trade as investors eye Fed minutes
29 December 2025
2 mins read

Mastercard slips in thin year-end trade as investors eye Fed minutes

NEW YORK, December 29, 2025, 13:30 ET — Regular session

  • Mastercard shares down about 0.2% in afternoon trading, mirroring a softer tape into year-end.
  • Payments peers Visa and American Express also traded lower as U.S. stocks wobbled after last week’s rally. 1
  • Traders are watching Tuesday’s Fed meeting minutes and Wednesday jobless claims in a holiday-shortened week. 2

Mastercard shares slipped on Monday as U.S. stocks eased in holiday-thinned trading in the final week of 2025. The payments company’s stock was down about 0.2% at $578.34 in afternoon New York trading. 1

The dip matters because markets are shifting from chasing momentum to protecting gains, with trading volumes expected to stay light into the New Year’s holiday. Investors are bracing for U.S. Federal Reserve meeting minutes and fresh labor-market data that can sway rate expectations and broad risk appetite. 1

Mastercard often trades as a proxy for consumer spending because it earns fees when cards are used at merchants. With few major corporate earnings on the calendar this week, macro headlines and year-end positioning are doing more of the work in day-to-day moves. 2

The stock traded between $577.38 and $581.99 earlier in the session, after closing Friday at $579.60, according to market data.

Rival Visa was down about 0.2%, while American Express fell roughly 1.2% in afternoon trade.

The broader market was lower as heavyweight technology names retreated from last week’s gains that pushed the S&P 500 to record highs, Reuters reported. Some investors have been watching whether a “Santa Claus rally” — a seasonal stretch when stocks often rise in late December and early January — can hold. 1

“This is not the beginning of the end of the tech dominance; it’ll turn out to be a buying opportunity,” Hank Smith, director and head of investment strategy at Haverford Trust, said of the market’s pullback. 1

For Mastercard, investors tend to focus on payment volumes and cross-border activity, which tracks spending on cards outside their issuing country and is a key profit driver for the networks. Those indicators are closely tied to travel and higher-end discretionary spending. 3

In its most recent results, Mastercard beat Wall Street profit expectations and reported net revenue up 17% in the quarter ended Sept. 30, while cross-border volume rose 15% on a local-currency basis, Reuters reported in October. 3

The company has also leaned on shareholder returns. On Dec. 9, Mastercard’s board raised its quarterly dividend 14% to 87 cents a share and approved a new share repurchase program authorizing up to $14 billion in buybacks, the company said. 4

Regulatory and legal risk remains part of the backdrop for the card networks. In November, Visa and Mastercard announced a revised $38 billion settlement with merchants over credit-card “swipe fees,” which still requires court approval, Reuters reported, while a separate class action over ATM access fees produced a proposed settlement filed in December. 5

What comes next is largely macro-driven. Investors are watching Tuesday’s Fed minutes and Wednesday’s weekly jobless claims report, with U.S. markets closed on Thursday for New Year’s Day and bond markets set to close early on Wednesday, according to Investopedia. 2

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Linde stock edges higher as tech retreat drags Wall Street in thin year-end trade
Previous Story

Linde stock edges higher as tech retreat drags Wall Street in thin year-end trade

Dow slips as Nvidia, Goldman drag blue chips in thin year-end trade
Next Story

Dow slips as Nvidia, Goldman drag blue chips in thin year-end trade

Go toTop